National Cancer Institute Amended; Notice of Meeting, 39765 [2018-17104]
Download as PDF
Federal Register / Vol. 83, No. 155 / Friday, August 10, 2018 / Notices
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Initial
Review Group; Neuroscience Review
Subcommittee.
Date: October 19, 2018.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Alcohol Abuse and
Alcoholism, 6700–B Rockledge Drive,
Conference Rooms A & B, Bethesda, MD
20817.
Contact Person: Beata Buzas, Ph.D.,
Scientific Review Officer, Office of
Extramural Activities, National Institute on
Alcohol Abuse and Alcoholism, 6700–B
Rockledge Drive, Room 2116, Bethesda, MD
20892, 301–443–0800, bbuzas@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards, National
Institutes of Health, HHS)
Dated: August 6, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–17105 Filed 8–9–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
daltland on DSKBBV9HB2PROD with NOTICES
National Cancer Institute Amended;
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Cancer
Advisory Board, August 14, 2018, 1:00
p.m. to August 14, 2018, 4:00 p.m.,
National Cancer Institute Shady Grove,
9609 Medical Center Drive, Conference
Room TE406, Rockville, MD 20850
which was published in the Federal
Register on August 02, 2018, 83 FR
37820.
The meeting notice is being amended
to change the meeting times for the open
and closed sessions. The open session
VerDate Sep<11>2014
19:03 Aug 09, 2018
Jkt 244001
will be held from 1:00 p.m. to 3:45 p.m.
The closed session will be held from
3:50 p.m. to 4:30 p.m. The meeting is
partially closed to the public.
Dated: August 6, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–17104 Filed 8–9–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer at (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Proposed Project: State Targeted
Response to the Opioid Crisis Grant
Program Mid-Year and End-Year
Performance Reports
(OMB No. 0930–0378)—In Use Without
OMB Approval
The Substance Abuse and Mental
Health Services Administration
(SAMHSA) is authorized under Section
1003 of the 21st Century Cures Act, as
amended, to support a grant program,
for up to 2 years, that addresses the
supplemental activities pertaining to
opioids currently undertaken by the
state agency or territory and will
PO 00000
Frm 00109
Fmt 4703
Sfmt 4703
39765
support a comprehensive response to
the opioid epidemic.
SAMHSA received approval from
OMB in September 2017 to collect
performance data from Opioid State
Targeted Response (STR) grantees (OMB
No. 0930–0378). However, SAMHSA
omitted a data collection table (Table E)
in the original OMB request. This data
table is currently in use by Opioid STR
grantees, who are reporting Table E data
to SAMHSA on a semi-annual basis. In
order to correct this violation, SAMHSA
is now seeking OMB approval for a new
data collection package that includes
not only the instruments originally
approved by OMB in September 2017,
but also this additional data collection
table. It is important for SAMHSA to
continue to collect this information in
order to assess the impact of funding
from the Opioid STR program on
increasing access to prevention
strategies, as well as treatment and
recovery services to address the opioid
crisis. Additionally, this data will
provide SAMHSA with critical
information to effectively manage the
Opioid STR program, to help states and
territories adopt, or scale-up, effective
practices and policies, and to help
prepare to implement the new State
Opioid Response grant program.
The primary purpose of the Opioid
STR program is to address the opioid
crisis by increasing access to treatment,
reducing unmet treatment need, and
reducing opioid overdose related deaths
through the provision of prevention,
treatment and recovery activities for
opioid use disorder (OUD) (including
prescription opioids as well as illicit
drugs such as heroin).
There are 57 (states and jurisdictions)
award recipients in this program. All
funded states and jurisdictions report on
their implementation and performance
through an online data collection
system. Award recipients report
performance on the following measures
specific to this program: number of
people who receive OUD treatment,
number of people who receive OUD
recovery services, number of providers
implementing medication-assisted
treatment, and the number of OUD
prevention and treatment providers
trained, to include nurse practitioners,
physician assistants, as well as
physicians, nurses, counselors, social
workers, case managers, etc. This
information is collected at the mid-point
and conclusion of each grant award
year. Additionally, each award recipient
describes the purposes for which the
grant funds received were expended and
the activities implemented under the
program.
E:\FR\FM\10AUN1.SGM
10AUN1
Agencies
[Federal Register Volume 83, Number 155 (Friday, August 10, 2018)]
[Notices]
[Page 39765]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-17104]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute Amended; Notice of Meeting
Notice is hereby given of a change in the meeting of the National
Cancer Advisory Board, August 14, 2018, 1:00 p.m. to August 14, 2018,
4:00 p.m., National Cancer Institute Shady Grove, 9609 Medical Center
Drive, Conference Room TE406, Rockville, MD 20850 which was published
in the Federal Register on August 02, 2018, 83 FR 37820.
The meeting notice is being amended to change the meeting times for
the open and closed sessions. The open session will be held from 1:00
p.m. to 3:45 p.m. The closed session will be held from 3:50 p.m. to
4:30 p.m. The meeting is partially closed to the public.
Dated: August 6, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-17104 Filed 8-9-18; 8:45 am]
BILLING CODE 4140-01-P